Proliferation index and survival in men with prostate cancer starting long-term androgen deprivation therapy in the STAMPEDE clinical trial. (2021)
Attributed to:
Developing Existing Healthcare Technologies to Deliver More Affordable and Effective Cancer Care
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1200/jco.2021.39.15_suppl.5076
Publication URI: http://dx.doi.org/10.1200/jco.2021.39.15_suppl.5076
Type: Journal Article/Review
Parent Publication: Journal of Clinical Oncology
Issue: 15_suppl